The patented design centers on a pivoting lever that exerts controlled pressure directly onto the internal adhesive ampoule. By depressing the lever, clinicians dispense the adhesive; releasing it immediately halts the flow. Dr. David Kay, founder of Resivant Medical, noted that this system allows for intermittent, precise dosing, preventing the common issue of adhesive runoff. When paired with the company's high-viscosity liquid, the applicator provides a level of stability previously unavailable in standard closure kits.
This intellectual property win reinforces the firm's broader portfolio, which encompasses both delivery hardware and proprietary chemical formulations. The Cutiva™ PLUS Skin Closure System, which utilizes this technology, has already received FDA clearance and is currently in use across domestic medical facilities. The development reflects a broader push by the Akron-based company to refine the ergonomics of surgical wound management.



Comments (0)
No comments yet. Be the first!